Citation Impact
Citing Papers
Pten Deficiency in Melanocytes Results in Resistance to Hair Graying and Susceptibility to Carcinogen-Induced Melanomagenesis
2008 StandoutNobel
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Highly Recurrent TERT Promoter Mutations in Human Melanoma
2013 StandoutScience
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
2010 StandoutNobel
Degradation of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, phosphatidylinositol 3'-kinase-AKT-dependent pathway.
2002
Basal cell carcinomas: attack of the hedgehog
2008 Standout
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients
2005
GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes
2008
The myc Oncogene: arvelouslomplex
2002
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma
2002
IDH1andIDH2Mutations in Gliomas
2009 Standout
Molecular genetic alterations in glioblastomas with oligodendroglial component
2001
Long survival and therapeutic responses in patient histologically disparate high-grade gliomas demonstrating chromosome 1p loss
2000
MYC on the Path to Cancer
2012 Standout
The WHO Classification of Tumors of the Nervous System
2002 Standout
The history of cancer epigenetics
2004 Standout
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Genome‐wide profiling of chromosomal alterations in renal cell carcinoma using high‐density single nucleotide polymorphism arrays
2009
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for Grade III and Grade IV oligoastrocytomas
1996
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
2006 Standout
Biomarkers in melanoma: predisposition, screening and diagnosis
2003
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
What is an Oligodendroglioma?
2002
Promoting apoptosis as a strategy for cancer drug discovery
2005
Phosphorylation of Human MAD1 by the BUB1 Kinasein Vitro
1999
Conserved synteny between the Fugu and human PTEN locus and the evolutionary conservation of vertebrate PTEN function
2001 StandoutNobel
Multicenter evaluation of the analytical and clinical performance of the Elecsys ® S100 immunoassay in patients with malignant melanoma
2005
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Genomic instability in Ip and human malignancies
1996
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Glioma Classification
2001
Role of autophagy in cancer
2007 Standout
HSP90 and the chaperoning of cancer
2005 Standout
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
1998 StandoutNobel
The Epigenomics of Cancer
2007 Standout
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β
2009
Molecular pathways in the formation of gliomas
1995
Tumour suppressor activity of human imprinted gene PEG3 in a glioma cell line
2001
Inflammation and Colon Cancer
2010 Standout
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
?Malignancy? in meningiomas
1999
Neural Stem Cells and the Origin of Gliomas
2005
Malignant glioma: Who benefits from adjuvant chemotherapy?
1998
PCV Chemotherapy for Recurrent Oligodendrogliomas and Oligoastrocytomas
1998
How to make a melanoma: what do we know of the primary clonal events?
2008
Malignant Gliomas in Adults
2008 Standout
A tiger behind many doors: multiple genetic pathways to malignant glioma
1995
Meningioma Grading
1997
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma
2004
Reflecting on 25 years with MYC
2008 Standout
Pilot Evaluation of 1p and 19q Deletions in Anaplastic Oligodendrogliomas Collected by a National Cooperative Cancer Treatment Group
2001
Oligodendroglioma: Toward Molecular Definitions in Diagnostic Neuro-Oncology
2003
Impact of Genotype and Morphology on the Prognosis of Glioblastoma
2002
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Multiple Inositol Polyphosphate Phosphatase: Evolution as a Distinct Group within the Histidine Phosphatase Family and Chromosomal Localization of the Human and Mouse Genes to Chromosomes 10q23 and 19
1999
Primary brain tumours in adults
2012 Standout
Defining the Role of mTOR in Cancer
2007 Standout
Glioblastomas with an Oligodendroglial Component: A Pathological and Molecular Study
2001
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
2010 StandoutNobel
Targeting STAT3 affects melanoma on multiple fronts
2005
Molecular Genetic Aspects of Oligodendrogliomas Including Analysis by Comparative Genomic Hybridization
1999
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
1997 Standout
Identification of human brain tumour initiating cells
2004 StandoutNature
Histopathological-Molecular Genetic Correlations in Referral Pathologist-Diagnosed Low-Grade “Oligodendroglioma”
2002
C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells
2008
The BCL-2 protein family: opposing activities that mediate cell death
2007 Standout
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
2014
Guidelines of care for the management of psoriasis and psoriatic arthritis
2009
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
2000 StandoutNature
Allelic Loss of 14q and 22q, NF2 Mutation, and Genetic Instability Occur Independently of c‐kit Mutation in Gastrointestinal Stromal Tumor
2000
Malignant melanoma: genetics and therapeutics in the genomic era
2006
Brain Tumors
2001 Standout
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Molecular Definition of Chromosome Translocations Involving 10q24 and 19q13 in Human Malignant Glioma Cells
1998
Maternally Expressed Gene 3, an Imprinted Noncoding RNA Gene, Is Associated with Meningioma Pathogenesis and Progression
2010
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
The Protein Kinase Complement of the Human Genome
2002 StandoutScience
Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas
2000
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Analysis of the PTEN gene in human meningiomas
1998
Platelet-derived Growth Factor and Its Receptor Expression in Human Oligodendrogliomas
1998
Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas
1998
Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis
2007
Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.
1998
Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19.
2002
Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression
1997
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.
2001
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy
1998
The 2007 WHO Classification of Tumours of the Central Nervous System
2010 Standout
Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors
1999
A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells
2008
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression
2001
Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis
2007
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci
2000
The E6 Oncoproteins of High-Risk Papillomaviruses Bind to a Novel Putative GAP Protein, E6TP1, and Target It for Degradation
1999
Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
2000 Standout
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Malignant glioma: genetics and biology of a grave matter
2001
c-Myc Interacts with Hypoxia to Induce Angiogenesis In vivo by a Vascular Endothelial Growth Factor-Dependent Mechanism
2004
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Works of Peter Kaskel being referenced
Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry
2012
Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil
2000
Outdoor activities in childhood: a protective factor for cutaneous melanoma? Results of a case-control study in 271 matched pairs
2001
Shared Allelic Losses on Chromosomes 1p and 19q Suggest a Common Origin of Oligodendroglioma and Oligoastrocytoma
1995
Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer
2001
S-100 protein in peripheral blood: A marker for melanoma metastases
1999
Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
2001
Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
2000
Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
1995
S100 beta is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase.
2001